Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    "Orbital lymphoma"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed
Has Results
Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma
Conditions: Non-Hodgkin's Lymphoma;   Lymphoma
Interventions: Drug: Rituximab;   Drug: Zevalin

Indicates status has not been verified in more than two years